Form 8-K - Current report:
SEC Accession No. 0001641172-25-016512
Filing Date
2025-06-25
Accepted
2025-06-25 17:17:08
Documents
13
Period of Report
2025-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 49652
  Complete submission text file 0001641172-25-016512.txt   244325

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rnxt-20250625.xsd EX-101.SCH 3014
3 XBRL DEFINITION FILE rnxt-20250625_def.xml EX-101.DEF 26189
4 XBRL LABEL FILE rnxt-20250625_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE rnxt-20250625_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3811
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 251074501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)